Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients. [electronic resource]
Producer: 20120525Description: 3031-7 p. digitalISSN:- 1528-0020
- Adult
- Dose-Response Relationship, Drug
- Factor VIII -- administration & dosage
- Half-Life
- Hemophilia A -- blood
- Humans
- Immunoglobulin Fc Fragments -- administration & dosage
- Infusion Pumps
- Male
- Metabolic Clearance Rate
- Middle Aged
- Receptors, Fc -- administration & dosage
- Recombinant Fusion Proteins -- administration & dosage
- Time Factors
- Young Adult
- von Willebrand Factor -- analysis
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.